Sjoerd T T Schetters
Overview
Explore the profile of Sjoerd T T Schetters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1075
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Haas A, Stolk D, Schetters S, Goossens-Kruijssen L, Keuning E, Ambrosini M, et al.
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794243
Cancer vaccines have emerged as a potent strategy to improve cancer immunity, with or without the combination of checkpoint blockade. In our investigation, liposomal formulations containing synthetic long peptides and...
2.
Schetters S, Dammeijer F, Desmet C
Front Immunol
. 2023 Dec;
14:1332852.
PMID: 38045688
No abstract available.
3.
Van Damme K, Hoste L, Declercq J, De Leeuw E, Maes B, Martens L, et al.
Sci Transl Med
. 2023 Aug;
15(710):eadi0252.
PMID: 37611083
Improvements in COVID-19 treatments, especially for the critically ill, require deeper understanding of the mechanisms driving disease pathology. The complement system is not only a crucial component of innate host...
4.
Rodriguez E, Boelaars K, Brown K, Madunic K, van Ee T, Dijk F, et al.
Commun Biol
. 2022 Jan;
5(1):41.
PMID: 35017635
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive malignancies with a 5-year survival rate of only 9%. Despite the fact that changes in glycosylation patterns during tumour progression...
5.
Schetters S, Schuijs M
Front Immunol
. 2021 Dec;
12:772004.
PMID: 34868033
Eosinophils are typically a minority population of circulating granulocytes being released from the bone-marrow as terminally differentiated cells. Besides their function in the defense against parasites and in promoting allergic...
6.
de Goede K, Verberk S, Baardman J, Harber K, van Kooyk Y, de Winther M, et al.
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34205266
Cancer cells rely on ATP-citrate lyase (Acly)-derived acetyl-CoA for lipid biogenesis and proliferation, marking Acly as a promising therapeutic target. However, inhibitors may have side effects on tumor-associated macrophages (TAMs)....
7.
Stolk D, Horrevorts S, Schetters S, Kruijssen L, Duinkerken S, Keuning E, et al.
Mol Ther Oncolytics
. 2021 Jun;
21:315-328.
PMID: 34141869
Induction of tumor-specific cytotoxic CD8 T cells (CTLs) via immunization relies on the presentation of tumor-associated peptides in major histocompatibility complex (MHC) class I molecules by dendritic cells (DCs). To...
8.
Rodriguez E, Boelaars K, Brown K, Li R, Kruijssen L, Bruijns S, et al.
Nat Commun
. 2021 Feb;
12(1):1270.
PMID: 33627655
Changes in glycosylation during tumour progression are a key hallmark of cancer. One of the glycan moieties generally overexpressed in cancer are sialic acids, which can induce immunomodulatory properties via...
9.
Schetters S, Kruijssen L, Crommentuijn M, Kalay H, den Haan J, van Kooyk Y
FASEB J
. 2021 Jan;
34(9):12406-12418.
PMID: 33411367
The clinically successful adjuvant MF59 is used in seasonal influenza vaccines, which is proposed to enhance immunity by creating an immune-competent microenvironment in the muscle that allows recruitment of immune...
10.
Schetters S, Li R, Kruijssen L, Engels S, Ambrosini M, Garcia-Vallejo J, et al.
Biomaterials
. 2020 Sep;
262:120342.
PMID: 32905903
Injection of antigenic peptides has been widely used as a vaccine strategy to boost T cell immunity. However, the poor immunogenicity of single peptides can potentially be strengthened through modification...